Safety of lamivudine treatment for chronic hepatitis B in early pregnancy

AIM: To evaluate the safety of lamivudine (LAM) treatment for chronic hepatitis B in early pregnancy. METHODS: A total of 92 pregnant women who received LAM treatment either before pregnancy or in early pregnancy were enrolled in this study. All of the pregnant women volunteered to take lamivudine d...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi, Wei, Liu, Min, Cai, Hao-Dong
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2012
Subjects:
Brief Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3516809/
https://ncbi.nlm.nih.gov/pubmed/23236240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i45.6645
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items